Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.

Korsten P, Sweiss NJ, Nagorsnik U, Niewold TB, Gröne HJ, Gross O, Müller GA.

Am J Kidney Dis. 2010 Dec;56(6):e17-21. doi: 10.1053/j.ajkd.2010.08.019. Epub 2010 Oct 25.

PMID:
20974510
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA.

Medicine (Baltimore). 2007 Jul;86(4):242-51.

PMID:
17632266
[PubMed - indexed for MEDLINE]
3.

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

Schabert VF, Watson C, Joseph GJ, Iversen P, Burudpakdee C, Harrison DJ.

J Manag Care Pharm. 2013 Oct;19(8):621-30.

PMID:
24074008
[PubMed - indexed for MEDLINE]
Free Article
4.

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.

Rudwaleit M, Van den Bosch F, Kron M, Kary S, Kupper H.

Arthritis Res Ther. 2010;12(3):R117. doi: 10.1186/ar3054. Epub 2010 Jun 16.

PMID:
20553600
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Adalimumab for the treatment of ankylosing spondylitis.

Sieper J, Rudwaleit M, Braun J.

Expert Opin Pharmacother. 2007 Apr;8(6):831-8.

PMID:
17425478
[PubMed - indexed for MEDLINE]
6.

Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.

Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G.

Am J Clin Dermatol. 2008;9(1):1-14. Review. Erratum in: Am J Clin Dermatol. 2008;9(5):347.

PMID:
18092839
[PubMed - indexed for MEDLINE]
7.

Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology.

Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A.

Int Ophthalmol. 2011 Apr;31(2):165-73. doi: 10.1007/s10792-011-9430-3. Epub 2011 Feb 2. Review.

PMID:
21287227
[PubMed - indexed for MEDLINE]
8.

Squamous cell carcinoma of the lip associated with adalimumab therapy for ankylosing spondylitis: a case report and review of TNF-α inhibitors and cutaneous carcinoma risk.

Zitelli KB, Zedek D, Ranganathan P, Amerson EH.

Cutis. 2013 Jul;92(1):35-9. Review.

PMID:
23961524
[PubMed - indexed for MEDLINE]
9.

Adalimumab (TNF α Inhibitor) Therapy Exacerbates IgA Glomerulonephritis Acute Renal Injury and Induces Lupus Autoantibodies in a Psoriasis Patient.

Wei SS, Sinniah R.

Case Rep Nephrol. 2013;2013:812781. doi: 10.1155/2013/812781. Epub 2013 Jul 24.

PMID:
24558628
[PubMed]
Free PMC Article
10.

Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France.

Saint Marcoux B, De Bandt M; CRI (Club Rhumatismes et Inflammation).

Joint Bone Spine. 2006 Dec;73(6):710-3. Epub 2006 Aug 30.

PMID:
17127088
[PubMed - indexed for MEDLINE]
11.

Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.

Famenini S, Wu JJ.

J Drugs Dermatol. 2013 Aug;12(8):939-43. Review.

PMID:
23986169
[PubMed - indexed for MEDLINE]
12.

Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature.

Hemmati I, Kur J.

Clin Rheumatol. 2013 Jul;32(7):1095-8. doi: 10.1007/s10067-013-2244-0. Epub 2013 Apr 5. Review.

PMID:
23559388
[PubMed - indexed for MEDLINE]
13.

Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?

Kocharla L, Mongey AB.

Lupus. 2009 Feb;18(2):169-71. doi: 10.1177/0961203308093922.

PMID:
19151120
[PubMed - indexed for MEDLINE]
14.

[Effectiveness and safety of biological therapy with adalimumab].

Fehér J, Lengyel G.

Orv Hetil. 2009 Jun 28;150(26):1215-22. doi: 10.1556/OH.2009.28681. Review. Hungarian.

PMID:
19546078
[PubMed - indexed for MEDLINE]
Free Article
15.

Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.

Lozeron P, Denier C, Lacroix C, Adams D.

Arch Neurol. 2009 Apr;66(4):490-7. doi: 10.1001/archneurol.2009.11.

PMID:
19364934
[PubMed - indexed for MEDLINE]
16.

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.

Tong D, Manolios N, Howe G, Spencer D.

Intern Med J. 2012 Jan;42(1):89-94.

PMID:
22389903
[PubMed - indexed for MEDLINE]
17.

Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.

Bonafede M, Fox KM, Watson C, Princic N, Gandra SR.

Adv Ther. 2012 Aug;29(8):664-74. doi: 10.1007/s12325-012-0037-5. Epub 2012 Aug 8.

PMID:
22886712
[PubMed - indexed for MEDLINE]
18.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.

Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2.

PMID:
23032984
[PubMed - indexed for MEDLINE]
19.

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.

Arends S, Brouwer E, van der Veer E, Groen H, Leijsma MK, Houtman PM, Th A Jansen TL, Kallenberg CG, Spoorenberg A.

Arthritis Res Ther. 2011 Jun 20;13(3):R94. doi: 10.1186/ar3369.

PMID:
21689401
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases.

Wiedmann MW, Mössner J, Baerwald C, Pierer M.

Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):295-314. Epub 2009 Sep 1. Review.

PMID:
19594416
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk